Key findings • Sarcoidosis patients are prone to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, increased severity, morbidity and greater mortality of coronavirus disease 2019 ...
Sarcoidosis is a systemic inflammatory disorder of unknown etiology, characterized by the formation of noncaseating granulomas, multisystem involvement, intrathoracic (pulmonary and lymph node ...
Dr. Jad Kebbe, a pulmonologist at the University of Oklahoma Health Sciences Center, discusses the risks of inhaling wildfire ...
With $75.1 million in cash and minimal competition, aTyr Pharma is well-positioned financially, making it a compelling high-risk, high-reward investment. Read more on ATYR stock here.
Xentria, a clinical-stage biopharmaceutical company advancing therapies for rare and serious diseases, today announced the successful completion of enrollment in the therapeutic dose-ranging phase of ...
From the departments of Medicine, Veterans Administration Hospital, George Washington University and Georgetown University. Washington, D. C. (address reprint requests to Dr. Becker at 50 Irving ...
Sarcoidosis can cause inflammation not only in the lungs but in other systems. And it's a cluster of cells of inflammation that can cause disease in lungs and other organs and can make people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback